Climate Change Data

Huakang Biomedical Holdings Company Limited

Climate Impact & Sustainability Data (2021)

Reporting Period: 2021

Environmental Metrics

Total Carbon Emissions:121.14 tCO2e/year
Scope 1 Emissions:10.2 tCO2e/year
Scope 2 Emissions:105.88 tCO2e/year
Scope 3 Emissions:6.02 tCO2e/year
Renewable Energy Share:Not disclosed
Total Energy Consumption:206,366 kWh/year
Water Consumption:1,870 m3/year
Waste Generated:3.9 tons/year (hazardous and non-hazardous combined)
Carbon Intensity:0.0026 tCO2eq. per unit of product sold

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Reduced GHG emissions by 28.4% per FTE and 25.7% per unit of product sold compared to 2020.
  • Reduced hazardous waste generation by 33.3% compared to 2020.
  • Reduced non-hazardous waste generation by 8.62% compared to 2020.

Social Achievements

  • Maintained Work Safety Standardization certification since 2016.
  • 98% of employees received training in 2021.
  • No work-related fatalities or injuries reported in 2021.

Governance Achievements

  • Established three board committees (Audit, Remuneration, and Nomination).
  • Complied with the Model Code for Securities Transactions.
  • Maintained liability insurance for Directors and officers.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Reduce emissions by 10% by 2030.
  • Reduce waste generation by 20% by 2030.
  • Reduce electricity use by 20% by 2030.
  • Reduce water use by 20% by 2030.
Short-term Goals:
  • Completion of Class II medical devices registration of the sperm nuclear DNA integrity reagent and market launch in 2022.

Environmental Challenges

  • Supply chain disruptions due to the COVID-19 pandemic and related travel restrictions and lockdowns.
  • Fluctuations in foreign exchange rates.
Mitigation Strategies
  • Diversified business into healthcare products and supplements.
  • Developed contingency plans and emergency procedures for workplace emergencies.
  • Closely monitored foreign currency exposure.

Supply Chain Management

Supplier Audits: Regular monitoring of supplier performance.

Responsible Procurement
  • Assessment of suppliers against criteria including production capability, environmental and social considerations, product efficacy and quality management systems.

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events disrupting supply chains.
Transition Risks
  • Regulatory changes and market shifts in response to climate change.
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: GEM Listing Rules Appendix 20 (ESG Reporting Guide)

Certifications: ISO 13485, Work Safety Standardization

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Shenzhen High and New Technology Enterprise
  • High and New Technology Enterprise
  • Certificate of Good Manufacturing Practice Rules for Medical Devices
  • Work Safety Standardization
  • ISO13485